Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
On Demand
Favorite
Facebook
Tweet
Print
Mona Amet, MPH
Adelphi Real World, United Kingdom
Disclosure(s): Adelphi Real World: Advisor/Consultant
Poster(s):
(P-396) PREFER-LA: People with HIV (PWH) in the United States with Prior Adherence Challenges with Oral Antiretroviral Therapy (ART) Prefer Cabotegravir + Rilpivirine Long-Acting (CAB+RPV LA) Therapy after Switch
Monday, October 20, 2025
12:15 PM - 1:30 PM
US ET
